Wang, Mengze
Xi, Yuzhen
Wang, Luoyu
Chen, Haonan
Jiang, Feng
Ding, Zhongxiang
Funding for this research was provided by:
National Natural Science Foundation of China (81871337)
Article History
Received: 18 September 2022
Accepted: 5 February 2024
First Online: 28 February 2024
Declarations
:
: The authors declare no competing interests.
: The studies involving human participants were reviewed and approved by the Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), and Affifiliated Hangzhou First People’s Hospital. Patients were exempted from giving informed consent after approval from both medical centers.
: Not applicable.